His main research concerns NAD+ kinase, Biochemistry, AMPK, Sirtuin 1 and Internal medicine. Biochemistry and Cell biology are frequently intertwined in his study. His AMPK study combines topics from a wide range of disciplines, such as FOXO1, Neuroscience and Resveratrol.
His study focuses on the intersection of Sirtuin 1 and fields such as Mitochondrion with connections in the field of Energy homeostasis and Poly ADP ribose polymerase. He has included themes like Metabolome, Endocrinology and SRT1720 in his Internal medicine study. Carles Cantó combines subjects such as Mitochondrial biogenesis and Glucose homeostasis with his study of AMP-activated protein kinase.
Carles Cantó focuses on NAD+ kinase, Endocrinology, Internal medicine, Mitochondrion and Biochemistry. He interconnects Sirtuin 1 and Metabolism in the investigation of issues within NAD+ kinase. The various areas that Carles Cantó examines in his Endocrinology study include mitochondrial fusion and AMPK.
His AMPK research includes themes of FOXO1, Resveratrol and Longevity. His work on Lipid metabolism, Carbohydrate metabolism and Glucose transporter as part of his general Internal medicine study is frequently connected to Energy source, thereby bridging the divide between different branches of science. His Mitochondrion research is multidisciplinary, incorporating elements of Oxidative stress, Poly ADP ribose polymerase, Neuroscience and Homeostasis.
His primary areas of study are NAD+ kinase, Nicotinamide riboside, Mitochondrion, Cell biology and Model organism. He has researched NAD+ kinase in several fields, including Endocrinology, Internal medicine, Homeostasis and Intracellular. Much of his study explores Endocrinology relationship to Mitochondrial biogenesis.
Biochemistry and Enzyme are the main topics of his Nicotinamide riboside study. His study on Progenitor cell, Stem cell and Endoplasmic reticulum is often connected to Asymmetric stem cell division as part of broader study in Cell biology. As part of the same scientific family, Carles Cantó usually focuses on Model organism, concentrating on Type 2 diabetes and intersecting with Insulin resistance.
His main research concerns Mitochondrion, Cell biology, Progenitor cell, Nicotinamide riboside and Asymmetric stem cell division. Carles Cantó integrates Mitochondrion and Phosphatidylserine in his studies. He integrates many fields, such as Phosphatidylserine and engineering, in his works.
MFN2 is closely attributed to Fatty liver in his work. His Progenitor cell study incorporates themes from Transplantation and NAD+ kinase.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity
Carles Cantó;Zachary Gerhart-Hines;Jerome N. Feige;Marie Lagouge.
PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.
Carles Cantó;Johan Auwerx.
Current Opinion in Lipidology (2009)
The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet induced obesity
Carles Cantó;Riekelt H. Houtkooper;Eija Pirinen;Eija Pirinen;Dou Y. Youn.
Cell Metabolism (2012)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Cantó;Lake Q. Jiang;Atul S. Deshmukh;Chikage Mataki.
Cell Metabolism (2010)
NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.
Carles Cantó;Keir J. Menzies;Johan Auwerx.
Cell Metabolism (2015)
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.
Riekelt H. Houtkooper;Carles Cantó;Ronald J. Wanders;Johan Auwerx.
Endocrine Reviews (2010)
Specific SIRT1 Activation Mimics Low Energy Levels and Protects against Diet-Induced Metabolic Disorders by Enhancing Fat Oxidation
Jérôme N. Feige;Marie Lagouge;Carles Canto;Axelle Strehle.
Cell Metabolism (2008)
The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling
Laurent Mouchiroud;Riekelt H. Houtkooper;Norman Moullan;Elena Katsyuba.
PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation
Péter Bai;Péter Bai;Carles Cantó;Hugues Oudart;Attila Brunyánszki.
Cell Metabolism (2011)
Caloric restriction, SIRT1 and longevity.
Carles Cantó;Johan Auwerx.
Trends in Endocrinology and Metabolism (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: